Literature DB >> 22901191

Reproductive variables and risk of breast malignant and benign tumours in Yunnan province, China.

Che Yanhua1, Alan Geater, Jing You, Li Li, Zhou Shaoqiang, Virasakdi Chongsuvivatwong, Hutcha Sriplung.   

Abstract

INTRODUCTION AND AIM: To compare reproductive factor influence on patients with pathological diagnosed malignant and benign tumor in the Breast Department, The First Peoples' Hospital of Kunming in Yunnan province, China.
METHODS: A hospital-based case-control study was conducted on 263 breast cancer (BC) cases and 457 non-breast cancer controls from 2009 to 2011. The cases and controls information on demographics, medical history, and reproductive characteristics variables were collected using a self-administered questionnaire and routine medical records. Histology of breast cancer tissue and benign breast lesion were documented by pathology reports. Since some variables in data analysis had zero count in at least one category, binomial-response GLM using the bias-reduction method was applied to estimate OR's and their 95% confidence intervals (95% CI). To adjust for age and menopause status, a compound variable comprising age and menopausal status was retained in the statistical models.
RESULTS: multivariate model analysis revealed significant independent positive associations of BC with short menstrual cycle, old age at first live birth, never breastfeeding, history of oral contraception experience, increased number of abortion, postmenopausal status, and nulliparity. Categorised by age and menopausal status, perimenopausal women had about 3-fold and postmenopausal women had more than 5-fold increased risk of BC compared to premenopausal women. DISCUSSION AND
CONCLUSION: This study has confirmed the significant association of BC and estrogen related risk factors of breast cancer including longer menstrual cycle, older age of first live birth, never breastfeeding, nulliparity, and number of abortions more than one. The findings suggest that female hormonal factors, especially the trend of menopause status play a significant role in the development of BC in Yunnan women.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22901191     DOI: 10.7314/apjcp.2012.13.5.2179

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  7 in total

Review 1.  Current status of breast cancer prevention in China.

Authors:  Fei Wang; Zhi-Gang Yu
Journal:  Chronic Dis Transl Med       Date:  2015-03-20

2.  Descriptive Epidemiology of Female Breast Cancer in Delhi, India

Authors:  Nalliah Manoharan; Omana Nair; N K Shukla; Goura Kishor Rath
Journal:  Asian Pac J Cancer Prev       Date:  2017-04-01

3.  Characterization of lncRNA LINC00520 and functional polymorphisms associated with breast cancer susceptibility in Chinese Han population.

Authors:  Qiaoyun Guo; Linping Xu; Rui Peng; Yan Ma; Yanli Wang; Feifei Chong; Mengmeng Song; Liping Dai; Chunhua Song
Journal:  Cancer Med       Date:  2020-01-29       Impact factor: 4.452

4.  Global patterns of breast cancer incidence and mortality: A population-based cancer registry data analysis from 2000 to 2020.

Authors:  Shaoyuan Lei; Rongshou Zheng; Siwei Zhang; Shaoming Wang; Ru Chen; Kexin Sun; Hongmei Zeng; Jiachen Zhou; Wenqiang Wei
Journal:  Cancer Commun (Lond)       Date:  2021-08-16

5.  Knowledge of a cancer diagnosis is a protective factor for the survival of patients with breast cancer: a retrospective cohort study.

Authors:  Chen He; Wen Xi Zhu; Yunxiang Tang; Yonghai Bai; Zheng Luo; Jinfang Xu; Hao Wang; Shuyu Xu; Jingzhou Xu; Lei Xiao; Ruike Zhang; Yajing Wang; Jing Du; Yujia Huang; Xiaopan Li; Tong Su
Journal:  BMC Cancer       Date:  2021-06-27       Impact factor: 4.430

6.  Incidence and mortality of female breast cancer in the Asia-Pacific region.

Authors:  Danny R Youlden; Susanna M Cramb; Cheng Har Yip; Peter D Baade
Journal:  Cancer Biol Med       Date:  2014-06       Impact factor: 4.248

7.  Genetic Profiling of Breast Cancer with and Without Preexisting Metabolic Disease.

Authors:  Wenjiang Jing; Ling Li; Xiumei Zhang; Shouxin Wu; Jiangman Zhao; Qunxing Hou; Haotian Wu; Wu Ma; Shuheng Li; Huimin Liu; Binhui Yang
Journal:  Transl Oncol       Date:  2019-12-21       Impact factor: 4.243

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.